The clinical use of antilymphocyte globulin.
D000818:Animals; D000917:Antibody Formation; D000941:Antigens; D000961:Antilymphocyte Serum / Q000008:administration & dosage / Q000009:adverse effects / Q000302:isolation & purification / Q000627:therapeutic use*; D001772:Blood Cell Count; D006087:Graft vs Host Reaction; D000882:Haplorhini; D006648:Histocompatibility; D006736:Horses; D006801:Humans; D006967:Hypersensitivity / Q000209:etiology; D007114:Immunization; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D007456:Iodine Isotopes; D016030:Kidney Transplantation; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000276:immunology; D008231:Lymphopenia / Q000209:etiology; D008722:Methods; D009103:Multiple Sclerosis / Q000276:immunology; D011817:Rabbits; D016038:Skin Transplantation; D014022:Tissue Survival; D014184:Transplantation, Homologous; D005719:gamma-Globulins / Q000627:therapeutic use
D000941:Antigens; D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D007456:Iodine Isotopes; D005719:gamma-Globulins